Loss of tau rescues inflammation-mediated neurodegeneration

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

<i>TREM2</i> Variants in Alzheimer's Disease

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · see citing works

Analysis of Fractalkine Receptor CX₃CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · see citing works

Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease

Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · see citing works

A new class of membrane-bound chemokine with a CX3C motif

Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013 · see citing works

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · see citing works

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · see citing works

Control of microglial neurotoxicity by the fractalkine receptor

Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · see citing works

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies

McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · see citing works

Untitled work

Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works

Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia

Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · see citing works

Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)

Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022 · see citing works

Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease

Saman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985 · see citing works

Tau is essential to β-amyloid-induced neurotoxicity

Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807 · see citing works

The myeloid cells of the central nervous system parenchyma

Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804 · see citing works

Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697 · see citing works

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., & Miller, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14500 · Cited by 692 · see citing works

Tumor Necrosis Factor-α-converting Enzyme (ADAM17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1)

Garton, K. J., Gough, P. J., Blobel, C., Murphy, G., Greaves, D. R., Dempsey, P. J., & Raines, E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106434200 · Cited by 639 · see citing works

Regulation of Tau Pathology by the Microglial Fractalkine Receptor

Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · see citing works

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration

Combadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618 · cited 2× · see citing works

High‐yield isolation of murine microglia by mild trypsinization

Saura, J., Tusell, J. M., & Serratosa, J. (2003) · Glia · doi:10.1002/glia.10274 · Cited by 595 · see citing works

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., & Meinl, E. (2009) · Brain · doi:10.1093/brain/awp300 · Cited by 595 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562 · see citing works

CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., & Lamb, B. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100265 · Cited by 539 · cited 2× · see citing works

Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486 · see citing works

Inflammation, autotoxicity and Alzheimer disease

McGeer, P. L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00289-5 · Cited by 474 · see citing works

Alzheimer Disease

Cummings, J. L. (2002) · JAMA · doi:10.1001/jama.287.18.2335 · Cited by 443 · see citing works

CD200 and membrane protein interactions in the control of myeloid cells

Barclay, A. N., Wright, G. J., Brooke, G. P., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416 · see citing works

Production and neuroprotective functions of fractalkine in the central nervous system.

Mizuno, T., Kawanokuchi, J., Numata, K., & Suzumura, A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02867-1 · Cited by 352 · see citing works

Tumor necrosis factor-α converting enzyme

Black, R. A. (2002) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/s1357-2725(01)00097-8 · Cited by 346 · see citing works

Neuron–glia crosstalk in health and disease: fractalkine and CX 3 CR1 take centre stage

Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 336 · see citing works

Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation

Shipton, O. A., Leitz, J. R., Dworzak, J., Acton, C. E. J., Tunbridge, E. M., Denk, F., Dawson, H. N., Vitek, M. P., Wade-Martins, R., Paulsen, O., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2610-10.2011 · Cited by 315 · see citing works

LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice

Lee, D. C., Rizer, J., Selenica, M.-L. B., Reid, P., Kraft, C., Johnson, A., Blair, L., Gordon, M. N., Dickey, C. A., & Morgan, D. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-56 · Cited by 293 · see citing works

Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis

Neumann, H., & Takahashi, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.032 · Cited by 249 · see citing works

Cell Mediators of Inflammation in the Alzheimer Disease Brain

Akiyama, H., Arai, T., Kondo, H., Tanno, E., Haga, C., & Ikeda, K. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00008 · Cited by 238 · see citing works

Microglial Activation parallels System Degeneration in progressive Supranuclear palsy and Corticobasal Degeneration

Ishizawa, K., & Dickson, D. W. (2001) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/60.6.647 · Cited by 209 · see citing works

The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events

Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M., & Lamb, B. T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-14 · Cited by 177 · see citing works

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

Jiao, S., Yao, X., Liu, Y.-H., Wang, Q., Zeng, F., Lu, J., Liu, J., Zhu, C., Shen, L., Liu, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422998112 · Cited by 173 · see citing works

In vivo imaging of microglial activation with [¹¹C](R)‐PK11195 PET in progressive supranuclear palsy

Gerhard, A., Trender‐Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P., & Brooks, D. J. (2006) · Movement Disorders · doi:10.1002/mds.20668 · Cited by 171 · see citing works

Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production

Mott, R. T., Ait‐Ghezala, G., Town, T., Mori, T., Vendrame, M., Zeng, J., Ehrhart, J. C., MULLAN, M. J., & Tan, J. (2004) · Glia · doi:10.1002/glia.20009 · Cited by 171 · see citing works

The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor

Stefano, L., Racchetti, G., Bianco, F., Passini, N., Gupta, R. S., Panina‐Bordignon, P., & Meldolesi, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06130.x · Cited by 150 · see citing works

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways

Žilka, N., Kazmerova, Z., Jadhav, S., Neradil, P., Maďari, A., Obetkova, D., Bugos, O., & Novák, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-47 · Cited by 147 · see citing works

In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration

Gerhard, A., Watts, J., Trender‐Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K. P., & Brooks, D. J. (2004) · Movement Disorders · doi:10.1002/mds.20162 · Cited by 145 · see citing works

Motor and cognitive deficits in aged tau knockout mice in two background strains

Lei, P., Ayton, S., Moon, S., Zhang, Q., Volitakis, I., Finkelstein, D. I., & Bush, A. I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-29 · Cited by 145 · see citing works

Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease

Dawson, H. N., Cantillana, V., Jansen, M., Wang, H., Vitek, M. P., Wilcock, D. M., Lynch, J., & Laskowitz, D. T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.037 · Cited by 137 · see citing works

Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion

Ahmed, T., Van der Jeugd, A., Blum, D., Galas, M.-C., D’Hooge, R., Buee, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.005 · Cited by 137 · see citing works

Inflammation occurs early during the Aβ deposition process in TgCRND8 mice

Dudal, S., Krzywkowski, P., Paquette, J., Morissette, C., Lacombe, D., Tremblay, P., & Gervais, F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.008 · Cited by 135 · see citing works

Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro

Ma, Q., Lim, G. P., Harris‐White, M. E., Yang, F., Ambegaokar, S. S., Ubeda, O. J., Glabe, C. G., Teter, B., Frautschy, S. A., & Cole, G. M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20734 · Cited by 126 · see citing works

Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice

López‐González, I., Schlüter, A., Aso, E., Garcia‐Esparcia, P., Ansoleaga, B., Llorens, F., Carmona, M., Moreno, J. R., Fuso, A., Portero‐Otín, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 125 · see citing works

Neuroinflammation‐induced acceleration of amyloid deposition in the APP^V717F transgenic mouse

Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119 · see citing works

Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy

Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108 · see citing works

Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease

Wes, P. D., Easton, A. E., Corradi, J., Barten, D. M., Devidze, N., DeCarr, L. B., Truong, A. B., He, A., Barrezueta, N. X., Polson, C. T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106050 · Cited by 105 · see citing works

Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy

Žilka, N., Stožická, Z., Kováč, A., Pilipcinec, E., Bugos, O., & Novák, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.013 · Cited by 98 · see citing works

Invited review: Animal models of tauopathies and their implications for research/translation into the clinic

Dujardin, S., Colin, M., & Buée, L. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 88 · see citing works

Neuroinflammation and Alzheimer Disease: Clinical and Therapeutic Implications

Eikelenboom, P., Rozemüller, A. J. M., Hoozemans, J. J. M., Veerhuis, R., & van Gool, W. A. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00009 · Cited by 78 · see citing works

Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes

Abbondante, S., Baglietto‐Vargas, D., Rodríguez‐Ortiz, C. J., Estrada-Hernandez, T., Medeiros, R., & LaFerla, F. M. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.021 · Cited by 45 · see citing works

Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies

Žilka, N., Korenova, M., & Novák, M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0499-y · Cited by 45 · see citing works

Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1.

Spulber, S., & Schultzberg, M. (2010) · Progress in neurobiology · doi:10.1016/j.pneurobio.2009.10.015 · Cited by 36 · see citing works

Tau deficiency leads to the upregulation of BAF‐57, a protein involved in neuron‐specific gene repression

Gómez de Barreda, E., Dawson, H. N., Vitek, M. P., & Avila, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.032 · Cited by 32 · see citing works

Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines

Oprica, M., Zhu, S., Goiny, M., Pham, T. M., Mohammed, A. H. S., Winblad, B. G., Bartfai, T., & Schultzberg, M. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.07.006 · Cited by 32 · see citing works

Aging and excitotoxic stress exacerbate neural circuit reorganization in amyloid precursor protein intracellular domain transgenic mice

Ghosal, K., & Pimplikar, S. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.020 · Cited by 24 · see citing works

The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease

Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8 · see citing works

Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease

Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532 · see citing works

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications

Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel‐Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 440 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Tau and neuroinflammation: what impact for Alzheimer's disease and tauopathies?

Laurent, C., Buée, L., & Blum, D. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.003 · Cited by 348 · see citing works

Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy

Cherry, J. D., Tripodis, Y., Alvarez, V. E., Huber, B., Kiernan, P. T., Daneshvar, D., Mez, J., Montenigro, P., Solomon, T. M., Alosco, M., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0382-8 · Cited by 267 · see citing works

Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J., et al. (2018) · Brain · doi:10.1093/brain/awy188 · Cited by 270 · see citing works

Intersection of pathological tau and microglia at the synapse

Vogels, T., Murgoci, A.-N., & Hromádka, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0754-y · Cited by 197 · see citing works

Cerebral dysfunctions caused by sepsis during ageing

Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191 · see citing works

Targeting microglia for the treatment of Alzheimer’s Disease

Wes, P. D., Sayed, F. A., Bard, F., & Gan, L. (2016) · Glia · doi:10.1002/glia.22988 · Cited by 185 · see citing works

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Sanchez-Mejias, E., Navarro, V., Jimenez, S., Sanchez-Mico, M., Sanchez-Varo, R., Nuñez-Diaz, C., Trujillo-Estrada, L., Davila, J. C., Vizuete, M., Gutierrez, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1630-5 · Cited by 175 · see citing works

The endotoxin hypothesis of Alzheimer’s disease

Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 140 · see citing works

Inflammasomes as therapeutic targets for A lzheimer's disease

White, C., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2016) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 131 · see citing works

Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model

Zhang, Z.-H., Wu, Q., Zheng, R., Chen, C., Chen, Y., Liu, Q., Hoffmann, P. R., Ni, J., & Song, G.-L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3229-16.2017 · Cited by 128 · see citing works

Targeting innate immunity for neurodegenerative disorders of the central nervous system

Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126 · see citing works

Novel function of Tau in regulating the effects of external stimuli on adult hippocampal neurogenesis

Pallas‐Bazarra, N., Jurado‐Arjona, J., Navarrete, M., Esteban, J. A., Hernández, F., Ávila, J., & Llorens‐Martín, M. (2016) · The EMBO Journal · doi:10.15252/embj.201593518 · Cited by 101 · see citing works

Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway

Jiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L., Duran, W., Peterson, C., Zimmerman, A., Mandell, M. A., Jett, S. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109720 · Cited by 92 · see citing works

Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction

Raz, L., Bhaskar, K., Weaver, J., Marini, S., Zhang, Q., Thompson, J. F., Espinoza, C., Iqbal, S., Maphis, N. M., Weston, L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.009 · Cited by 84 · see citing works

In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease

Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79 · see citing works

Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice

Jin, G., Bai, D., Yin, S., Yang, Z., Zou, D., Zhang, Z., Li, X., Sun, Y., & Zhu, Q. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.008 · Cited by 70 · see citing works

Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology

Kulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 69 · see citing works

PET molecular imaging for pathophysiological visualization in Alzheimer’s disease

Wang, J., Jin, C., Zhou, J., Zhou, R., Tian, M., Lee, H. J., & Zhang, H. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05999-z · Cited by 66 · see citing works

Microglia: Friend and foe in tauopathy

Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60 · see citing works

Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease

Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 60 · see citing works

Mitophagy Regulates Neurodegenerative Diseases

Cen, X., Zhang, M., Zhou, M., Ye, L., & Xia, H. (2021) · Cells · doi:10.3390/cells10081876 · Cited by 58 · see citing works

Sleep Disruption Exacerbates and Prolongs the Inflammatory Response to Traumatic Brain Injury

Tapp, Z. M., Kumar, J. E., Witcher, K. G., Atluri, R. R., Velasquez, J., O’Neil, S. M., Dziabis, J. E., Bray, C. E., Sheridan, J. F., Godbout, J. P., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7010 · Cited by 53 · see citing works

Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain

Wheeler, J. M., McMillan, P. J., Strovas, T. J., Liachko, N. F., Amlie‐Wolf, A., Kow, R. L., Klein, R. L., Szot, P., Robinson, L., Guthrie, C. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao6545 · Cited by 44 · see citing works

The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease

Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47 · see citing works

Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses

Podvin, S., Jones, A. C., Liu, Q., Aulston, B. D., Ransom, L., Ames, J., Shen, G., Lietz, C. B., Jiang, Z., O’Donoghue, A. J., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002079 · Cited by 47 · see citing works

Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis

Putra, M. R. E., Puttachary, S., Liu, G., Lee, G. S., & Thippeswamy, T. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592374 · Cited by 47 · see citing works

Tau as a potential therapeutic target for ischemic stroke

Chen, X., & Jiang, H. (2019) · Aging · doi:10.18632/aging.102547 · Cited by 44 · see citing works

Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells

Maysinger, D., Ji, J. X., Hutter, E., & COOPER, E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00480 · Cited by 43 · see citing works

Neuronal levels and sequence of tau modulate the power of brain rhythms

Das, M. M., Maeda, S., Hu, B., Yu, G.-Q., Guo, W., Lopez, I., Yu, X., Tai, C., Wang, X., & Mucke, L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.020 · Cited by 41 · see citing works

Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells

Yeo, E. T. Y., Wong, K. W. L., See, M. L., Wong, K. Y., Gan, S. Y., & Chan, E. W. L. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.02.025 · Cited by 40 · see citing works

A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders

Perdoncin, M., Konrad, A., Wyner, J. R., Lohana, S., Pillai, S. S., Pereira, D. G., Lakhani, H. V., & Sodhi, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756499 · Cited by 38 · see citing works

Lipids and brain inflammation in APOE4-associated dementia

Duro, M. V. V., Ebright, B., & Yassine, H. N. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000801 · Cited by 38 · see citing works

Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast‐Induced Traumatic Brain Injury

Du, X., West, M., Cheng, W., Ewert, D. L., Li, W., Saunders, D., Towner, R. A., Floyd, R. A., & Kopke, R. D. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4159357 · Cited by 35 · see citing works

High Selectivity and Sensitivity of Oligomeric p-Phenylene Ethynylenes for Detecting Fibrillar and Prefibrillar Amyloid Protein Aggregates

Fanni, A. M., Monge, F. A., Lin, C., Thapa, A., Bhaskar, K., Whitten, D. G., & Chi, E. Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00719 · Cited by 35 · see citing works

Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies

Bakota, L., Ussif, A. M., Jeserich, G., & Brandt, R. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.03.003 · Cited by 32 · see citing works

Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 31 · see citing works

Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer’s Disease and Mild Cognitive Impairment patients

Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, A. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577561 · Cited by 31 · see citing works

Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer’s Disease

Jiang, S., & Bhaskar, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161123 · Cited by 30 · see citing works

Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study

Su, L., Surendranathan, A., Huang, Y., Bevan-Jones, W. R., Passamonti, L., Hong, Y. T., Arnold, R. J., Rodríguez, P. V., Wang, Y., Mak, E., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.10.006 · Cited by 30 · see citing works

Cognitive effects of the GSK-3 inhibitor “lithium” in LPS/chronic mild stress rat model of depression: Hippocampal and cortical neuroinflammation and tauopathy

Ebeid, M. A., Habib, M. Z., Mohamed, A. M., el Faramawy, Y., Saad, S. S. T., El-Kharashi, O. A., Magdoub, H. M. E., Abd-Alkhalek, H. A., Aboul‐Fotouh, S., & Abdel-Tawab, A. M. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2020.12.016 · Cited by 30 · see citing works

Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology

Romero‐Molina, C., Navarro, V., Sanchez-Varo, R. M., Jiménez, S., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Muñoz‐Castro, C., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00421 · Cited by 25 · see citing works

Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer’s Disease

Zhang, H., Wang, D., Gong, P., Lin, A., Zhang, Y., Ye, R. D., & Yu, Y. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180823 · Cited by 26 · see citing works

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type

Pluta, R. M., Czuczwar, S. J., Januszewski, S., & Jabłoński, M. (2021) · Cells · doi:10.3390/cells10092213 · Cited by 24 · see citing works

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics

Hassan-Abdi, R., Brenet, A., Bennis, M., Yanicostas, C., & Soussi‐Yanicostas, N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01199 · Cited by 25 · see citing works

Tau mRNA 3′UTR-to-CDS ratio is increased in Alzheimer disease

García‐Escudero, V., Gargini, R., Martín-Maestro, P., García, E., García‐Escudero, R., & Ávila, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.007 · Cited by 25 · see citing works

Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy

Bemiller, S. M., Maphis, N. M., Formica, S. V., Wilson, G. N., Miller, C. M., Xu, G., Kokiko-Cochran, O. N., Kim, K.-W., Jung, S., Cannon, J. L., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1310-6 · Cited by 24 · see citing works

The Alz-tau Biomarker for Alzheimer’s Disease: Study in a Caucasian Population

Guzmán‐Martínez, L., Tapia, J. P., Farias, G. A., González, A., Estrella, M., & Maccioni, R. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180637 · Cited by 24 · see citing works

Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease

Daulatzai, M. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9643-3 · Cited by 25 · see citing works

RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer’s disease

Rubinsztein, D. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715241114 · Cited by 23 · see citing works

Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters

Ponomarenko, P. M., Витальевна, Ч. И., Рассказов, Д. А., Sharypova, E. B., Kashina, E. V., Drachkova, I. A., Zhechev, D. A., Ponomarenko, M. P., Savinkova, L. K., & Kolchanov, N. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00231 · Cited by 22 · see citing works

Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer’s Disease Brains

Chaudhary, S., Ashok, A., McDonald, D., Wise, A. S., Kritikos, A. E., Rana, N. A., Harding, C. V., & Singh, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210221 · Cited by 22 · see citing works

The persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics

Coleman, L. G., Crews, F. T., & Vetreno, R. P. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.08.001 · Cited by 22 · see citing works

A Levee to the Flood: Pre-injury Neuroinflammation and Immune Stress Influence Traumatic Brain Injury Outcome

Houle, S., & Kokiko‐Cochran, O. N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.788055 · Cited by 20 · see citing works

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

Goñi, F., Martá-Ariza, M., Herline, K., Peyser, D. K., Boutajangout, A., Mehta, P. D., Drummond, E., Prelli, F. C., & Wısnıewskı, T. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0337-3 · Cited by 20 · see citing works

Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam‐era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD‐ADNI) study

Clark, A. L., Weigand, A. J., Bangen, K. J., Thomas, K. R., Eglit, G. M. L., Bondi, M. W., Delano‐Wood, L., & Initiative, A. D. N. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12239 · Cited by 20 · see citing works

PET Imaging of Epigenetic Influences on Alzheimer’s Disease

Couto, P. J., & Millis, R. M. (2015) · International Journal of Alzheimer's Disease · doi:10.1155/2015/575078 · Cited by 19 · see citing works

Implications for microglial sex differences in tau-related neurodegenerative diseases

Doust, Y. V., King, A. E., & Ziebell, J. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.010 · Cited by 18 · see citing works

Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy

Sirkis, D. W., Solsberg, C. W., Johnson, T. P., Bonham, L. W., Sturm, V. E., Lee, S. E., Rankin, K. P., Rosen, H. J., Boxer, A. L., Seeley, W. W., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01205-3 · Cited by 17 · see citing works

Deficiency but Not Supplementation of Selenium Impairs the Hippocampal Long-Term Potentiation and Hippocampus-Dependent Learning

Babür, E., Tan, B., Yousef, M., Cinbaş, S., Süer, C., & Dursun, N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01666-x · Cited by 18 · see citing works

Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model

Houben, S., Leroy, K., Ando, K., Yilmaz, Z., Widomski, C., Buée, L., & Brion, J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.021 · Cited by 15 · see citing works

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Chandra, S., & Vassar, R. J. (2024) · Immunological Reviews · doi:10.1111/imr.13412 · Cited by 14 · see citing works

Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury

Wang, T., Yang, X., Qi, Z., Wang, G.-X., Xia, P., Hou, T., & Zhou, H. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.177744 · Cited by 12 · see citing works

Chronic inflammation: a potential target in tauopathies

Ising, C., & Heneka, M. T. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00116-3 · Cited by 10 · see citing works

Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy

Katsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 10 · see citing works

Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation–Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus

Li, Y., Wen, G., Ding, R., Ren, X., Jing, C., Liu, L., Yao, J., Zhang, G., Lu, Y., Li, B., et al. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01613-9 · Cited by 10 · see citing works

Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase

Lauretti, E., & Praticò, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179931 · Cited by 9 · see citing works

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model

Hulse, J. P., Maphis, N. M., Peabody, J., Bondu, V., Chackerian, B., & Bhaskar, K. (2025) · npj Vaccines · doi:10.1038/s41541-025-01147-4 · Cited by 9 · see citing works

Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective

Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 10 · see citing works

Cerebrospinal Fluid Inflammatory Markers in Alzheimer’s Disease: Influence of Comorbidities

Wang, Y., Emre, C., Gyllenhammar-Schill, H., Fjellman, K., Eyjolfsdottir, H., Eriksdotter, M., Schultzberg, M., & Hjorth, E. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210330162207 · Cited by 8 · see citing works

Beyond Neuroinflammation: Microglia at the Crossroads of Amyloid, Tau, and Neurodegeneration in Alzheimer’s Disease

Ebrahimi, R., Bordbar, S., Azad, G., Davoody, S., Mahmoudi, M., & Esmaeilpour, K. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08403-4 · Cited by 8 · see citing works

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice

Houben, S., de Fisenne, M.-A., Ando, K., Dries, V. V., Poncelet, L., Yilmaz, Z., Mansour, S., Decker, R. D., Brion, J., & Leroy, K. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00106 · Cited by 7 · see citing works

Synaptic proteome perturbations after maternal immune activation: Identification of embryonic and adult hippocampal changes

Yotova, A. Y., Li, L., O’Leary, A., Tegeder, I., Reif, A., Courtney, M. J., Slattery, D. A., & Freudenberg, F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.040 · Cited by 7 · see citing works

Ultrasound‐Assisted H 2 Transmitter Enables Hydrogen‐Gene Therapy to Prevent Anesthesia/Surgery‐Induced Cognitive Impairment

Zhan, R., Yan, F., Lou, C.-Y., Chen, N., Mo, X., Jiao, B., Liu, M., Zhao, Y., Xu, W., Xu, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202414397 · Cited by 6 · see citing works

Sex-Differences in Traumatic Brain Injury in the Absence of Tau in Drosophila

Shah, E. J., Gurdziel, K., & Ruden, D. M. (2021) · Genes · doi:10.3390/genes12060917 · Cited by 6 · see citing works

Global Deficiency of Alzheimer’s Disease Risk Gene Il1rap Reduces Pathological Tau in a Mouse Model of Systemic Inflammation

Dadras, S., & Bhaskar, K. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2598310 · Cited by 3 · see citing works

Dysferlin Protein–Protein Interaction Pathways in the Organ of Corti and Spiral Ganglion Intersect with Alzheimer’s Protein Pathways

Drescher, M. J., Drescher, D. G., Khan, K. M., Hatfield, J. S., & Hemani, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199559 · Cited by 2 · see citing works

GluN2A–NMDAR mediated neuronal NFκB activation plays a key role in exacerbating ischemic brain injury under hyperhomocysteinemic conditions

Seelig, S., Paramasivam, P., Gomez, M., Smith, A., Miller, J. W., Paul, S., & Poddar, R. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251399012 · Cited by 2 · see citing works

RIPK 1 in Alzheimer’s Disease: Research Progress Integrating Pathogenesis on Necroptosis-Related Neuroinflammation, and Potential Therapeutic Strategies

Toklucu, E. S., Shen, S., Wang, C., & Zhang, C. (2026) · Biomedicines · doi:10.3390/biomedicines14051155 · Cited by 2 · see citing works

Impaired Signaling of NF-κB and NRF2 in CX3CR1-Deficient Microglia: Implications in TauopathiesPreprint

Castro‐Sánchez, S., García‐Yagüe, Á. J., Kügler, S., & Lastres‐Becker, I. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/346304 · Cited by 2 · see citing works

Proteopathic Tau Primes and Activates Interleukin-1ß(Il-1ß) via MyD88- and NLRP3-ASC-Inflammasome Dependent PathwaysPreprint

Jiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L. L., Duran, W., Floruta, C. M., Zimmerman, A. J., Jett, S. D., Bigio, E. H., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3379896 · Cited by 1 · see citing works

AAV-mediated STC-1 expression mitigates neuroinflammation and preserves visual function in degenerative retinopathy

Wang, Y., Li, S., Zhang, C., Li, M., Wang, K., Wang, G., Tao, Y., & Song, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06898-1 · Cited by 1 · see citing works

Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathyPreprint

Hulse, J. P., Maphis, N. M., Peabody, J., Chackerian, B., & Bhaskar, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.05.588338 · Cited by 1 · see citing works

Comorbid Pathology in Chronic Traumatic Encephalopathy

Stein, T. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-54425-2.00008-4

Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathyPreprint

Sirkis, D. W., Solsberg, C. W., Johnson, T. P., Bonham, L. W., Sturm, V. E., Lee, S. E., Rankin, K. P., Rosen, H. J., Boxer, A. L., Seeley, W. W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.28.514304

Translational study on the role of genetic and prenatal risk factors in neurodevelopmental psychiatric disorders

Yotova, A. Y. (2024) · doi:10.21248/gups.85791

Effets de l’administration de tétrahydrobioptérine en condition physiologique et pathologique : De la neurobiologie au comportement

Fanet, H. (2018) · theses.fr (ABES) · doi:10.70675/b46d2065zecc9z4e97zae20zf9e2e4fe0c69

Tau knockout mitigates long-term cognitive impairment following neonatal sepsis via mechanisms involving dendritic structural remodelling and adult hippocampal neurogenesis

Li, H., Yu, B., Wang, B., Sun, L., Zhao, C., Hu, L., Yuan, M., & Wang, H. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03917-w

Neuron p

(2016)

O2–01–04: Inflammatory pathways link amyloid and tau pathology

Lamb, B. T., Lee, S., Xu, G., & Ransohoff, R. M. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.04.138

Regulation of Tau Pathology by the Microglial Fractalkine Receptor

Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · see citing works

F2‐03‐06: The Opposing Roles of Neuronal‐Microglial Communication in Alzheimer's Disease

Lamb, B. T. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.827

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain

Maphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Brain · doi:10.1093/brain/awv081 · Cited by 595 · see citing works